|
GB8808015D0
(en)
|
1988-04-06 |
1988-05-05 |
Ritter M A |
Chemical compounds
|
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
JPH06510750A
(ja)
|
1991-05-03 |
1994-12-01 |
セラジェン インク |
炎症性関節炎治療を目的としてインタ−ロイキン受容体を標的にした分子
|
|
JP3315427B2
(ja)
|
1992-03-05 |
2002-08-19 |
大日本除蟲菊株式会社 |
皮膚炎治療剤
|
|
US5714146A
(en)
|
1992-08-26 |
1998-02-03 |
Board Of Regents Of The University Of Washington |
IL-4 bone therapy
|
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
|
RU2162711C2
(ru)
|
1993-09-07 |
2001-02-10 |
Смитклайн Бичам Корпорейшн |
Рекомбинантные il4-антитела, используемые для лечения нарушений, связанных с действием il4
|
|
WO2000016804A1
(en)
|
1998-09-18 |
2000-03-30 |
Dynavax Technologies Corporation |
METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN
|
|
EP2990420B1
(en)
|
2000-05-26 |
2016-12-21 |
Immunex Corporation |
Use of interleukin-4 receptor antibodies and compositions thereof
|
|
US7879328B2
(en)
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
WO2002007745A1
(fr)
|
2000-07-26 |
2002-01-31 |
Yuuzou Tsuchida |
Compositions antipruritiques et compositions favorisant la suberification des blessures
|
|
US20030103938A1
(en)
|
2001-05-09 |
2003-06-05 |
Alk-Abello A/S |
Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
|
|
US20050031609A1
(en)
|
2001-05-11 |
2005-02-10 |
Thomas Hultsch |
Compositions for use in treating ige-associated disorders
|
|
DK1450855T3
(da)
|
2001-05-23 |
2010-01-11 |
Duotol Ab |
Undertrykkelse af allergiske reaktioner ved hjælp af transdermal indgivelse af allergener i forbindelse med eller konjugeret til toxin-underenheder eller fragmenter deraf
|
|
EP1461300B1
(en)
|
2001-11-30 |
2011-07-27 |
Biogen Idec MA Inc. |
Antibodies against monocyte chemotactic proteins
|
|
ES2327830T3
(es)
|
2002-03-29 |
2009-11-04 |
Schering Corporation |
Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen.
|
|
SI2000481T1
(sl)
|
2003-02-01 |
2016-08-31 |
Tanox, Inc. |
Anti-humana protitelesa IgE z visoko afiniteto
|
|
US7923209B2
(en)
|
2003-03-14 |
2011-04-12 |
Anergis, S.A. |
Allergen peptide fragments and use thereof
|
|
MXPA06004853A
(es)
|
2003-11-07 |
2006-07-06 |
Immunex Corp |
Anticuerpos que se aglutinan al receptor 4 de interleucina.
|
|
CA2550933A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Methods for identifying functional antibodies
|
|
AU2005219837A1
(en)
|
2004-02-27 |
2005-09-15 |
Regeneron Pharmaceuticals, Inc. |
IL-4/IL-13 sepecific polypetides and therapeutic uses thereof
|
|
US20090098142A1
(en)
|
2004-06-09 |
2009-04-16 |
Kasaian Marion T |
Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
JP5234445B2
(ja)
|
2004-10-05 |
2013-07-10 |
源一郎 杣 |
薬剤
|
|
US8030003B2
(en)
|
2004-12-07 |
2011-10-04 |
Children's Hospital Medical Center |
Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3
|
|
TW200902555A
(en)
|
2005-01-03 |
2009-01-16 |
Hoffmann La Roche |
Antibodies against IL-13 receptor alpha 1 and uses thereof
|
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US8679545B2
(en)
|
2005-11-12 |
2014-03-25 |
The Regents Of The University Of California |
Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
JP4221018B2
(ja)
|
2006-08-31 |
2009-02-12 |
トヨタ自動車株式会社 |
頭部保護エアバッグ装置
|
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
|
CN101522716B
(zh)
|
2006-10-02 |
2013-03-20 |
瑞泽恩制药公司 |
抗人il-4受体的高亲和力人抗体
|
|
PT2132230E
(pt)
|
2007-03-22 |
2014-07-17 |
Genentech Inc |
Anticorpos apoptóticos anti-ige que se ligam ao ige ligado a membrana
|
|
EP2022507A1
(en)
|
2007-08-07 |
2009-02-11 |
Universität Hamburg |
Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
|
|
US8637239B2
(en)
|
2007-11-05 |
2014-01-28 |
The Board Of Trustees Of The University Of Illinois |
Minimally-invasive measurement of esophageal inflammation
|
|
US8092804B2
(en)
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
|
DE202008006598U1
(de)
|
2008-04-11 |
2008-10-02 |
Alk-Abelló A/S |
Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
|
|
US20090264392A1
(en)
|
2008-04-21 |
2009-10-22 |
Meritage Pharma, Inc. |
Treating eosinophilic esophagitis
|
|
EP2376656A4
(en)
|
2008-12-01 |
2012-05-16 |
Cincinnati Children S Hospital Medical Ct |
METHOD AND DETERMINATION OF THE EFFECTIVENESS OF A GLUCOCORTICOID TREATMENT OF EOSINOPHILIAN ESOPHAGITIS
|
|
WO2010120524A2
(en)
|
2009-03-31 |
2010-10-21 |
Altair Therapeutics, Inc. |
Methods of modulating an immune response to a viral infection
|
|
US8497528B2
(en)
|
2010-05-06 |
2013-07-30 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Method for fabricating a strained structure
|
|
CN102596237A
(zh)
|
2009-09-07 |
2012-07-18 |
Dbv技术公司 |
治疗嗜酸细胞性食管炎的方法
|
|
US8993347B2
(en)
|
2009-12-17 |
2015-03-31 |
Cornell University |
Methods for detecting antibodies in mucosal samples and device for sampling mucosal material
|
|
US20120164080A1
(en)
|
2010-06-24 |
2012-06-28 |
Meritage Pharma, Inc. |
Methods of treatment for esophageal inflammation
|
|
BR112013008366B1
(pt)
|
2010-10-06 |
2022-02-08 |
Regeneron Pharmaceuticals, Inc |
Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações
|
|
RU2453303C1
(ru)
|
2010-12-23 |
2012-06-20 |
Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") |
Фармацевтическая композиция для лечения атопического дерматита
|
|
WO2012094643A2
(en)
|
2011-01-06 |
2012-07-12 |
Children's Hospital Medical Center |
Esophageal cytokine expression profiles in eosinophilic esophagitis
|
|
US20130052190A1
(en)
|
2011-02-22 |
2013-02-28 |
Oxagen Limited |
CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions
|
|
EP2723899B1
(en)
|
2011-06-21 |
2020-11-18 |
Children's Hospital Medical Center |
Diagnostic methods for eosinophilic esophagitis
|
|
CN103974706A
(zh)
|
2011-10-06 |
2014-08-06 |
N·V·努特里奇亚 |
嗜酸细胞性食管炎的治疗
|
|
EP2790696A1
(en)
|
2011-12-16 |
2014-10-22 |
Atopix Therapeutics Limited |
Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
|
|
KR20140119777A
(ko)
|
2012-01-31 |
2014-10-10 |
제넨테크, 인크. |
항-ig-e m1'' 항체 및 그의 사용 방법
|
|
WO2013155010A1
(en)
|
2012-04-09 |
2013-10-17 |
Children's Hospital Medical Center |
Non-invasive biomarkers for eosinophilic esophagitis
|
|
JP6306588B2
(ja)
|
2012-08-21 |
2018-04-04 |
サノフィ・バイオテクノロジー |
Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
|
|
PL2892927T3
(pl)
*
|
2012-09-07 |
2018-11-30 |
Regeneron Pharmaceuticals, Inc. |
Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R
|
|
US10132809B2
(en)
|
2012-10-10 |
2018-11-20 |
Rhote Island Hospital |
Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
|
|
JP6636803B2
(ja)
|
2013-02-05 |
2020-01-29 |
エンクマフ エスアーエールエル |
Ｂｃｍａに対する抗体の選択のための方法
|
|
TWI755763B
(zh)
|
2013-06-04 |
2022-02-21 |
美商再生元醫藥公司 |
藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
|
|
AU2014284235C1
(en)
|
2013-06-21 |
2025-07-31 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating nasal polyposis by administering an IL-4R antagonist
|
|
TWI634900B
(zh)
|
2013-07-11 |
2018-09-11 |
再生元醫藥公司 |
藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法
|
|
IL315136A
(en)
|
2014-02-21 |
2024-10-01 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-4rantagonist
|
|
KR102695088B1
(ko)
|
2014-02-28 |
2024-08-16 |
리제너론 파아마슈티컬스, 인크. |
Ｉｌ-4ｒ 길항제의 투여에 의한 피부 감염의 치료 방법
|
|
CA3246946A1
(en)
*
|
2014-11-14 |
2025-11-29 |
Sanofi Biotechnology |
Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
|
|
ES2983475T3
(es)
|
2016-02-19 |
2024-10-23 |
Regeneron Pharma |
Métodos para mejorar la eficacia de una vacuna mediante la administración de un antagonista de IL-4R
|
|
CN113372446A
(zh)
|
2016-06-08 |
2021-09-10 |
苏州康乃德生物医药有限公司 |
用于结合白细胞介素4受体的抗体
|
|
TWI728172B
(zh)
|
2016-08-18 |
2021-05-21 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
ES2994774T3
(en)
|
2016-09-01 |
2025-01-31 |
Regeneron Pharma |
Methods for preventing or treating allergy by administering an il-4r antagonist
|
|
WO2018057776A1
(en)
|
2016-09-22 |
2018-03-29 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating severe atopic dermatitis by administering an il-4r inhibitor
|
|
IL268349B2
(en)
|
2017-02-17 |
2024-08-01 |
Hutchinson Fred Cancer Res |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
|
EP3615068A1
(en)
|
2017-04-28 |
2020-03-04 |
Novartis AG |
Bcma-targeting agent, and combination therapy with a gamma secretase inhibitor
|
|
US11053309B2
(en)
|
2017-08-04 |
2021-07-06 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating active eosinophilic esophagitis
|
|
KR102694419B1
(ko)
|
2017-10-30 |
2024-08-09 |
사노피 바이오테크놀로지 |
Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법
|
|
CN113597328B
(zh)
|
2019-03-21 |
2025-10-31 |
瑞泽恩制药公司 |
用于治疗过敏症的il-4/il-13途径抑制剂和浆细胞消融的组合
|
|
JP7836754B2
(ja)
|
2019-08-05 |
2026-03-27 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｉｌ－４ｒアンタゴニストを投与することによりアレルギーを治療しアレルゲン特異的免疫療法を増強するための方法
|
|
CN114173816A
(zh)
|
2019-08-05 |
2022-03-11 |
瑞泽恩制药公司 |
通过施用il-4r拮抗剂治疗特应性皮炎的方法
|
|
JP2023527775A
(ja)
|
2020-05-22 |
2023-06-30 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｉｌ－４ｒ阻害剤の投与により好酸球性食道炎を処置する方法
|